Finasteride Therapy
Introduction to Finasteride
- Finasteride commonly causes sexual side effects including decreased libido, ejaculatory dysfunction, and erectile dysfunction, which are reversible upon discontinuation but may persist in some patients after stopping the medication 1
Efficacy and Safety
- Finasteride reduces serum PSA levels by approximately 50% after 12 months of therapy, which is clinically important because PSA levels must be doubled when screening for prostate cancer in men taking finasteride 2
- Finasteride reduces serum PSA levels by approximately 50% after 12 months of therapy, which is clinically important because failure to account for this reduction could mask the detection of prostate cancer 3
- Most side effects are reversible upon discontinuation 1
- However, post-finasteride syndrome has been reported - a controversial condition involving persistent sexual, physical, and psychological symptoms after stopping the medication 4
- The FDA has added a warning about potential persistent sexual side effects to the drug label, though the evidence is based primarily on anecdotal reports rather than prospective trials 4
Special Considerations
- In geriatric patients, carefully weigh medication burden against benefits, as side effects may have greater impact on quality of life 5
Monitoring and Patient Education
- Discuss potential side effects with patients before initiating therapy, including the risk of persistent sexual dysfunction, and monitor for sexual dysfunction, breast changes, and mood alterations 4